tirzepatide and zepbound the same vs Mounjaro: Drug, Different Uses FDA Approves Tirzepatide (Zepbound) as

Retatrutide adds a third pathway: glucagon activity increased fat oxidation + metabolic acceleration This triple agonist design appears to outperform tirzepatide in early trials, particularly for individuals with severe obesity or strong metabolic resistance

Some people drop 5-10 pounds quickly (often water weight)

fruit on high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats

If your BMI is 27 or over, you may qualify if you have prediabetes (with a blood sugar A1C level of 5.7 to 6.4), a history of heart attack or stroke, or blocked leg arteries that cause symptoms

What the label describes as glutathione may in practice be partially spent material

The Track Record: Multiple large-scale studies show average weight loss of 12-15% over 68 weeks